Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$14.94
-4.32%
Mkt Cap $1.54B
Analyst Ratings
No recent rating data.
Price Target (46 analysts)
$46.80
Range $30.00 – $67.00
Implied Upside
+213.3%
Consensus $46.80 vs current $14.94